Thomas R. Spitzer

Also affiliated with Massachusetts General Hospital, Harvard Stem Cell Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial”.

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood(2022)10.1182/blood.2021014738

N/A

4.5DataRank · unranked

141 citations

Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003847

N/A

0.735DataRank · unranked

133 citations

Kathleen Gallagher, Yi‐Bin Chen, Mark B. Leick, Steven L. McAfee, Areej El‐Jawahri +11 more

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

Blood Advances(2024)10.1182/bloodadvances.2024012556

N/A

0.724DataRank · unranked

23 citations

Ashish Damania, Haesook T. Kim, Chia‐Chi Chang, Areej El‐Jawahri, Steven L. McAfee +20 more

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant

PLoS ONE(2021)10.1371/journal.pone.0252995

N/A

0DataRank · unranked

5 citations

Sharareh Siamakpour‐Reihani, Lauren Bohannan, Yi Ren, Alexander B. Sibley, Jeff Sheng +24 more